Physiologically Based Pharmacokinetics Joined With In Vitro–In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
Top Cited Papers
- 30 May 2012
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 92 (1), 50-61
- https://doi.org/10.1038/clpt.2012.65
Abstract
Classic pharmacokinetics (PK) rarely takes into account the full knowledge of physiology and biology of the human body. However, physiologically based PK (PBPK) is built mainly from drug-independent "system" information. PBPK is not a new concept, but it has shown a very rapid rise in recent years. This has been attributed to a greater connectivity to in vitro-in vivo extrapolation (IVIVE) techniques for predicting drug absorption, distribution, metabolism, and excretion (ADME) and their variability in humans. The marriage between PBPK and IVIVE under the overarching umbrella of "systems biology" has removed many constraints related to cutoff approaches on prediction of ADME. PBPK-IVIVE linked models have repeatedly shown their value in guiding decisions when predicting the effects of intrinsic and extrinsic factors on PK of drugs. A review of the achievements and shortcomings of the models might suggest better strategies in extending the success of PBPK-IVIVE to pharmacodynamics (PD) and drug safety.Keywords
This publication has 69 references indexed in Scilit:
- From preclinical to human – prediction of oral absorption and drug–drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case exampleBiopharmaceutics & Drug Disposition, 2012
- Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?Biopharmaceutics & Drug Disposition, 2012
- Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studiesBiopharmaceutics & Drug Disposition, 2012
- Utility of a physiologically–based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug–drug–disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practiceBiopharmaceutics & Drug Disposition, 2012
- Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism‐based adverse eventsBiopharmaceutics & Drug Disposition, 2012
- Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practicePediatric Anesthesia, 2011
- Physiologically-Based Pharmacokinetics in Drug Development and Regulatory ScienceAnnual Review of Pharmacology and Toxicology, 2011
- Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory ReviewClinical Pharmacology & Therapeutics, 2010
- Torsten Teorell, the Father of PharmacokineticsUpsala Journal of Medical Sciences, 1995
- STUDIES ON THE DIFFUSION EFFECT UPON IONIC DISTRIBUTIONThe Journal of general physiology, 1937